National Health Investors Inc (NHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $3.09B
Last updated: Nov 17, 2026 at 11:06 AM ET
National Health Investors Inc (NHI) Financials: Revenue, Profit and Cash Flow
National Health Investors reported revenue of $375.63M for the fiscal year ended Dec 31, 2025, up 12.1% from the year before. That year, net income was $140.79M with a net margin of 37.5%, operating cash flow was $236.56M and free cash flow was -$37.51M. The quarter ended Sep 30, 2026 had revenue of $113.48M and net income of $563.21M.
Revenue and Margins
The operating margin was 51.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $248.46M, a compound annual rate of 4.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $375.63M | +12.1% | 100.0% | 51.7% | 37.5% |
| Dec 2024 | $335.18M | +4.8% | 100.0% | 54.7% | 40.8% |
| Dec 2023 | $319.83M | +4.3% | 100.0% | 55.4% | 42.0% |
| Dec 2022 | $306.54M | +2.6% | 100.0% | 21.1% | 21.4% |
| Dec 2021 | $298.71M | -10.2% | 100.0% | 27.6% | 37.5% |
| Dec 2020 | $332.81M | +4.6% | 100.0% | 51.4% | 55.7% |
| Dec 2019 | $318.08M | +8.0% | 100.0% | 50.7% | 50.4% |
| Dec 2018 | $294.61M | +5.7% | 100.0% | 52.6% | 52.4% |
| Dec 2017 | $278.66M | +12.2% | 100.0% | 54.4% | 57.2% |
| Dec 2016 | $248.46M | N/A | 100.0% | 47.8% | 61.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 3.0% from the year before. In the quarter ended Sep 2026, net income rose 1634.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $375.63M | $335.18M | $319.83M | $306.54M | $298.71M | $332.81M | $318.08M | $294.61M | $278.66M | $248.46M |
| Gross profit | $375.63M | $335.18M | $319.83M | $306.54M | $298.71M | $332.81M | $318.08M | $294.61M | $278.66M | $248.46M |
| Operating income | $194.03M | $183.20M | $177.12M | $64.68M | $82.58M | $171.04M | $161.27M | $155.07M | $151.49M | $118.77M |
| Net income | $140.79M | $136.64M | $134.38M | $65.50M | $111.97M | $185.31M | $160.45M | $154.33M | $159.37M | $152.72M |
| EBITDA | $280.84M | $274.14M | $266.79M | $147.64M | $200.52M | $280.04M | $242.71M | $230.58M | $234.14M | $217.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113.48M | $121.32M | $115.13M | $105.71M | $89.85M | $90.66M | $89.30M | $84.24M | $82.94M | $86.49M | $81.51M | $79.47M |
| Gross profit | $113.48M | $121.32M | $115.13M | $105.71M | $89.85M | $90.66M | $89.30M | $84.24M | $82.94M | $86.49M | $81.51M | $79.47M |
| Operating income | $29.77M | $49.79M | $52.15M | $78.97M | $46.06M | $35.05M | $47.63M | $74.97M | $28.24M | $34.72M | $45.27M | $58.82M |
| Net income | $563.21M | $55.36M | $39.75M | $37.80M | $32.48M | $36.69M | $33.82M | $42.79M | $28.24M | $34.95M | $30.66M | $31.72M |
Balance Sheet
As of Dec 2025, total debt of $1.29B exceeded cash and equivalents by $1.27B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.80B | $2.61B | $2.49B | $2.51B | $2.84B | $3.12B | $3.04B | $2.75B | $2.55B | $2.40B |
| Current assets | $19.62M | $24.29M | $22.35M | $19.29M | $37.41M | $43.34M | $5.21M | $4.66M | $3.06M | $4.64M |
| Cash and equivalents | $19.62M | $24.29M | $22.35M | $19.29M | $37.41M | $43.34M | $5.21M | $4.66M | $3.06M | $4.64M |
| Total liabilities | $1.26B | $1.23B | $1.21B | $1.22B | $1.32B | $1.60B | $1.54B | $1.36B | $1.22B | $1.19B |
| Short-term debt | $125.00M | $331.20M | $245.00M | $415.41M | $75.39M | $458.37M | $1.23M | $22.81M | $21.27M | $15.86M |
| Long-term debt | $1.16B | $1.15B | $1.14B | $1.15B | $1.24B | $1.50B | $1.44B | $1.28B | $1.15B | $1.12B |
| Shareholder equity | $1.52B | $1.37B | $1.25B | $1.27B | $1.51B | $1.51B | $1.50B | $1.39B | $1.32B | $1.21B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.24B | $2.96B | $2.89B | $2.80B | $2.69B | $2.70B | $2.78B | $2.61B | $2.46B | $2.48B | $2.48B | $2.49B |
| Total liabilities | $1.14B | $1.37B | $1.36B | $1.26B | $1.19B | $1.20B | $1.34B | $1.23B | $1.21B | $1.21B | $1.21B | $1.21B |
| Cash and equivalents | $46.56M | $30.39M | $24.95M | $19.62M | $81.63M | $18.64M | $135.00M | $24.29M | $15.55M | $14.77M | $11.36M | $22.35M |
| Shareholder equity | $2.09B | $1.57B | $1.51B | $1.52B | $1.48B | $1.48B | $1.43B | $1.37B | $1.23B | $1.24B | $1.25B | $1.25B |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $236.56M | $207.77M | $184.45M | $185.34M | $210.86M | $232.15M | $240.96M | $207.87M | $198.09M | $176.64M |
| Capital expenditures | $274.07M | $138.13M | $38.08M | $6.36M | $46.82M | $102.71M | $219.19M | $131.76M | $175.79M | $362.63M |
| Free cash flow | -$37.51M | $69.64M | $146.37M | $178.98M | $164.04M | $129.44M | $21.77M | $76.11M | $22.30M | -$186.00M |
| Dividends paid | $170.61M | $157.66M | $157.52M | $162.69M | $183.81M | $195.33M | $179.75M | $165.39M | $153.04M | $139.87M |
| Share repurchases | $767.00K | $930.00K | $0 | $152.02M | $0 | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$269.15M | -$192.31M | -$11.63M | $197.94M | $185.28M | -$89.71M | -$342.52M | -$250.29M | -$163.85M | -$329.84M |
| Financing cash flow | $25.71M | -$13.57M | -$169.72M | -$401.25M | -$402.99M | -$111.76M | $107.32M | $44.26M | -$35.05M | $144.16M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $47.98M | $64.97M | $53.44M | $67.74M | $62.53M | $59.82M | $46.48M | $57.57M | $48.63M | $60.74M | $40.83M | $53.20M |
| Capital expenditures | $18.03M | $124.40M | $105.49M | $143.08M | $9.85M | $56.50M | $74.48M | $128.26M | $4.68M | $6.89M | $2.98M | $1.16M |
| Free cash flow | $29.95M | -$59.42M | -$52.05M | -$75.35M | $52.68M | $3.32M | -$28.01M | -$70.69M | $43.95M | $53.85M | $37.85M | $52.04M |
Frequently Asked Questions About NHI
What is National Health Investors' annual revenue?
National Health Investors reported revenue of $375.63M for the fiscal year ended Dec 31, 2025.
How fast is National Health Investors' revenue growing?
Revenue was up 12.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 7.0%.
Is National Health Investors profitable?
Yes. National Health Investors reported net income of $140.79M for the fiscal year ended Dec 31, 2025, with a net margin of 37.5%.
How much free cash flow does NHI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $236.56M minus capital expenditures of $274.07M produced free cash flow of -$37.51M.
How much debt does National Health Investors have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.16B, short-term debt of $125.00M and cash and equivalents of $19.62M.
NHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors